Interaction of vasoactive agents and micro-emboli on the pulmonary circulation.
D000628:Aminophylline / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D003533:Cyproheptadine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D004617:Embolism; D006213:Hallucinogens / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011652:Pulmonary Circulation / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D014655:Vascular Resistance / Q000187:drug effects
D006213:Hallucinogens; D012702:Serotonin Antagonists; D000804:Angiotensin II; D000628:Aminophylline; D003533:Cyproheptadine; D012701:Serotonin; D006632:Histamine; D003913:Dextroamphetamine; D009638:Norepinephrine; D008784:Methysergide